Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
1100.00Today’s High
1145.2052W low
600.0052W High
1224.00Open Price
1110.80Prev. Close
1018.0500Volume
13436.00Value
15278747.40Fundamentals
Market Cap
2807.70
Price to Earnings
33.00
Price to Book Value
3.80
Dividend Yield
4.20
PE to Growth
-1.90
Op Revenue TTM
335.07
Net Profit TTM
85.19
Cash From Operating Activity
113.40
Return on Equity %
11.43
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
70.9
Week
80.1
Month
77.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1127.45
PIVOT
First Resistance
1154.95
Second Resistance
1172.75
Third Resistance
1200.25
First Support
1109.65
Second Support
1082.15
Third Support
1064.35
Relative Strength Index
70.23
Money Flow Index
56.36
MACD
13.99
MACD Signal
11.59
Average True Range
30.03
Average Directional Index
10.17
Rate of Change (21)
11.72
Rate of Change (125)
41.44
Commodity Channel Index
170.9
Williams %R
-9.6
BETA
1 Month
0.28
3 Month
0.64
1 Year
0.59
3 Year
0.31
PRICE CHANGE ANALYSIS
↑ 3%
1 Week
Low
High
1092.3
1145.25
↑ 11.72%
1 Month
Low
High
1006.4
1145.25
↑ 4.23%
3 Months
Low
High
930
1148
↑ 41.57%
6 Months
Low
High
786
1224
↑ 35.77%
1 Year
Low
High
599.95
1224
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 91.59 | 106.50 | 95.64 | 103.07 | 92.50 | 88.53 | 108.38 | 147.44 | 112.63 | 105.00 | 110.86 | |
| Operating Expenses Qtr | 69.96 | 64.77 | 61.85 | 73.28 | 66.81 | 72.53 | 85.20 | 89.12 | 92.70 | 92.40 | 97.39 | |
| Operating Profit Qtr | 11.21 | 19.77 | 16.91 | 17.32 | 9.32 | 7.64 | 16.32 | 31.80 | 5.62 | 6.56 | 7.09 | |
| EBIDT Qtr Cr | 21.63 | 41.73 | 33.79 | 29.79 | 25.69 | 16.00 | 23.18 | 58.32 | -29.71 | 12.60 | 13.47 | |
| Depreciation Qtr | 0.14 | 0.26 | 0.65 | 1.56 | 2.08 | 1.30 | 1.38 | 1.30 | 1.31 | 2.75 | 2.68 | |
| Net Profit Qtr | 14.68 | 26.57 | 23.68 | 20.26 | 25.02 | 7.61 | 18.35 | 52.38 | -23.37 | 6.35 | 7.02 | |
| Basic EPS Qtr | 28.56 | 10.76 | 9.59 | 8.21 | 10.13 | 3.08 | 7.43 | 21.21 | -9.47 | 2.57 | 2.84 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 396.75 | 436.85 | 433.06 | 414.44 | 474.39 | |
| Operating Expenses Annual Cr | 269.81 | 313.66 | 372.76 | 354.56 | 426.22 | |
| Operating Profit Annual | 65.26 | 65.08 | 27.11 | 26.79 | 12.03 | |
| Operating Profit Margin Annual % | 16.45 | 14.90 | 6.26 | 6.46 | 2.54 | |
| Total Expenses Annual Cr | 273.91 | 321.47 | 387.24 | 374.40 | 445.75 | |
| EBIDT Annual Cr | 126.94 | 123.19 | 60.30 | 59.88 | 48.17 | |
| EBIDT Annual margin % | 31.99 | 28.20 | 13.92 | 14.45 | 10.15 | |
| Depreciation | 2.61 | 6.06 | 9.65 | 12.16 | 13.14 | |
| PAT Before ExtraOrdinary Items Annual Cr | 85.19 | 103.36 | -3.72 | 20.90 | 10.08 | |
| Net Profit Annual | 85.19 | 103.36 | -3.72 | 20.90 | 10.08 | |
| Basic EPS Annual | 34.50 | 41.86 | -1.51 | 8.46 | 4.08 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 744.82 | 775.66 | 691.70 | 711.19 | 720.73 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 22.91 | 47.79 | 49.45 | 132.15 | 124.12 | |
| Total Current Liabilities Annual Cr | 157.20 | 159.49 | 216.42 | 158.95 | 232.79 | |
| Total Capital Plus Liabilities Annual Cr | 924.93 | 982.94 | 957.57 | 1002.29 | 1077.64 | |
| Fixed Assets Annual | 6.94 | 19.25 | 23.65 | 63.91 | 76.28 | |
| Total Non Current Assets Annual | 225.67 | 305.61 | 248.84 | 278.25 | 264.51 | |
| Total Current Assets Annual | 699.26 | 677.33 | 708.73 | 724.04 | 813.13 | |
| Total Assets Annual | 924.93 | 982.94 | 957.57 | 1002.29 | 1077.64 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 419.25 | 422.34 | 431.36 | 406.30 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 113.40 | 44.80 | 38.67 | -69.21 | -23.14 | |
| Cash from Investing Activity Annual | 33.13 | -153.25 | 87.04 | 95.16 | 55.91 | |
| Cash from Financing Annual Activity | -120.99 | -30.48 | -35.63 | -36.80 | -41.41 | |
| Net Cash Flow Annual | - | -138.93 | 90.08 | -10.85 | -8.64 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 301.79 | 314.29 | 280.27 | 288.16 | 292.03 | |
| ROE Annual % | 11.43 | 13.32 | -0.53 | 2.93 | 1.39 | |
| ROCE Annual % | 16.19 | 14.22 | 6.83 | 5.65 | 4.14 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 37.88 | 32.52 | 15.07 | 15.70 | 10.99 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Novartis AG | 70.68 | 74543457 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 1.2 | 74543467 |
| Atul Limited | 1.52 | 74543473 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 20, 2023 | 37.5 | SPECIAL | - | Equity Share |
| Jul 20, 2023 | 10 | FINAL | - | Equity Share |
| Jul 20, 2022 | 10 | FINAL | - | Equity Share |
| Aug 17, 2021 | 10 | FINAL | - | Equity Share |
| Jul 29, 2020 | 10 | FINAL | - | Equity Share |
| Jul 31, 2019 | 10 | FINAL | - | Equity Share |
| Jul 18, 2018 | 10 | FINAL | - | Equity Share |
| Jul 19, 2017 | 10 | FINAL | - | Equity Share |
| Jul 21, 2016 | 10 | FINAL | Jul 22, 2016 | Equity Share |
| Jul 14, 2015 | 10 | FINAL | - | Equity Share |
| Jul 16, 2014 | 10 | FINAL | - | Equity Share |
| Jul 16, 2013 | 10 | FINAL | - | Equity Share |
| Jul 18, 2012 | 10 | FINAL | - | Equity Share |
| Jul 18, 2011 | 10 | FINAL | - | Equity Share |
| Jul 21, 2010 | 10 | FINAL | - | Equity Share |
| Jul 08, 2009 | 10 | FINAL | - | Equity Share |
| Jul 07, 2008 | 10 | FINAL | - | Equity Share |
| Mar 22, 2007 | 10 | INTERIM | Mar 23, 2007 | Equity Share |
| Jul 19, 2006 | 15 | FINAL | - | Equity Share |
| Jul 20, 2005 | 10 | FINAL | - | Equity Share |
| Jul 14, 2004 | 10 | FINAL | - | Equity Share |
| Jul 21, 2003 | 7.5 | FINAL | - | Equity Share |
| Jul 02, 2002 | - | FINAL | - | Equity Share |
| Oct 03, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Nov 06, 2000 | 10:5 | 2000-11-06 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 10, 2024 | Audited Results & Final Dividend | - |
| Jan 25, 2024 | Quarterly Results | - |
| Oct 27, 2023 | Quarterly Results | - |
| Jul 26, 2023 | Quarterly Results | - |
| May 10, 2023 | Audited Results, Final & Special Dividend | - |
| Feb 08, 2023 | Quarterly Results | - |
| Nov 09, 2022 | Quarterly Results | - |
| Jul 27, 2022 | Quarterly Results | - |
| May 19, 2022 | Audited Results & Final Dividend | - |
| Feb 10, 2022 | Quarterly Results | - |
| Nov 11, 2021 | Quarterly Results | - |
| Aug 11, 2021 | Quarterly Results | - |
| Jun 17, 2021 | Audited Results & Final Dividend | (Revised) |
| May 20, 2021 | Audited Results & Final Dividend | - |
| Feb 11, 2021 | Quarterly Results | - |
| Nov 05, 2020 | Quarterly Results | - |
| Aug 06, 2020 | Quarterly Results | - |
| Jun 19, 2020 | Audited Results & Final Dividend | - |
| Feb 11, 2020 | Quarterly Results | - |
| Nov 08, 2019 | Quarterly Results | - |
| Aug 08, 2019 | Quarterly Results | - |
| May 23, 2019 | Audited Results & Final Dividend | - |
| Feb 04, 2019 | Quarterly Results | - |
| Nov 13, 2018 | Quarterly Results | - |
| Jul 26, 2018 | Quarterly Results | - |
| May 10, 2018 | Audited Results & Final Dividend | - |
| Jan 29, 2018 | Quarterly Results | - |
| Nov 10, 2017 | Quarterly Results | - |
| Sep 25, 2017 | Buy Back of Shares | - |
| Jul 27, 2017 | Quarterly Results | - |
| May 23, 2017 | Audited Results & Final Dividend | - |
| Feb 03, 2017 | Quarterly Results | - |
| Nov 11, 2016 | Quarterly Results | - |
| Jul 28, 2016 | Quarterly Results | Resignation of Mr. Girish Tekchandani, Company Secretary & Compliance Officer. |
| Jun 13, 2016 | Appointment of Additional Director | - |
| May 26, 2016 | Audited Results & Dividend | - |
| Apr 19, 2016 | Appointment of Additional Director | - |
| Feb 11, 2016 | Quarterly Results | Inter alia, took on record the resignation of Ms. Manisha Girotra as Independent Director of the Company w.e.f. February 11, 2016. |
| Nov 05, 2015 | Quarterly Results | - |
| Jul 22, 2015 | Quarterly Results | - |
| May 27, 2015 | Audited Results & Dividend | - |
| Feb 04, 2015 | Quarterly Results | - |
| Nov 07, 2014 | Quarterly Results | - |
| Jul 25, 2014 | Quarterly Results | - |
| May 22, 2014 | Audited Results & Dividend | - |
| Jan 23, 2014 | Quarterly Results | - |
| Oct 30, 2013 | Quarterly Results | - |
| Jul 24, 2013 | Quarterly Results | - |
| May 14, 2013 | Audited Results & Dividend | - |
| Jan 23, 2013 | Quarterly Results | - |
| Oct 25, 2012 | Quarterly Results | - |
| Jul 25, 2012 | Quarterly Results | - |
| May 24, 2012 | Audited Results & Dividend | - |
| Jan 30, 2012 | Quarterly Results | - |
| Oct 31, 2011 | Quarterly Results | - |
| Jul 25, 2011 | Quarterly Results | - |
| Mar 24, 2011 | Audited Results & Dividend | - |
| Jan 31, 2011 | Quarterly Results | - |
| Oct 21, 2010 | Quarterly Results | - |
| Jul 29, 2010 | Quarterly Results | - |
| May 07, 2010 | Audited Results, Dividend & Others | The Board has considered the Delisting of Shares from the Calcutta Stock Exchange, subject to Shareholders and other related approval. |
| Jan 19, 2010 | Quarterly Results | - |
| Oct 29, 2009 | Quarterly Results | - |
| Jul 16, 2009 | Quarterly Results | - |
| May 08, 2009 | Audited Results & Dividend | - |
| Mar 12, 2009 | To accept resignation of Director's | Inter alia, to accept the resignation of Ms. Asha Mirchandani & Dr. Jesus Acebillo, Directors, effective from the date of the Board meeting. |
| Jan 22, 2009 | Quarterly Results | - |
| Oct 17, 2008 | Quarterly Results | - |
| Jul 15, 2008 | Quarterly Results | - |
| May 09, 2008 | Audited Results & Dividend | - |
| Jan 25, 2008 | Quarterly Results | - |
| Oct 23, 2007 | Quarterly Results | - |
| Jul 19, 2007 | Quarterly Results | - |
| May 11, 2007 | Audited Results & Dividend | - |
| Mar 17, 2007 | Interim Dividend | - |
| Jan 25, 2007 | Quarterly Results | - |
| Oct 27, 2006 | Quarterly Results | - |
| Jul 27, 2006 | Quarterly Results | - |
| May 19, 2006 | Accounts & Dividend | - |
| Jan 27, 2006 | Quarterly Results | - |
| Oct 21, 2005 | Quarterly Results | - |
| Jul 28, 2005 | Quarterly Results | - |
| May 20, 2005 | Accounts & Dividend | - |
| Jan 28, 2005 | Quarterly Results | - |
| Oct 29, 2004 | Quarterly Results | - |
| Jul 22, 2004 | Quarterly Results | - |
| May 14, 2004 | Dividend & Accounts | - |
| Oct 30, 2003 | Quarterly Results | - |
| Jul 29, 2003 | Quarterly Results | - |
| May 26, 2003 | Dividend, Accounts & Others | Buy Back of Shares |
| Jan 30, 2003 | Quarterly Results | - |
| Oct 25, 2002 | Half Yearly Results | - |
| Jul 26, 2002 | Quarterly Results | - |
| Apr 30, 2002 | Accounts & Dividend | - |
| Jan 25, 2002 | Quarterly Results | - |
| Oct 30, 2001 | Half Yearly Results | - |
| Sep 01, 2001 | Accounts & Dividend | - |
| Aug 16, 2001 | Amalgamation | Amalgamation with Ciba CKD Biochem Ltd., |
| Jul 27, 2001 | Quarterly Results | - |
| Jun 29, 2001 | Accounts | - |
| Mar 09, 2001 | Amalgamation | Scheme of Amalgamation of CIBA CKD Biochem Ltd. with the co. |
| Jan 18, 2001 | Quarterly Results | - |
| Oct 25, 2000 | Quarterly Results | - |
| Jul 28, 2000 | Quarterly Results | - |
| May 30, 2000 | Accounts & Scheme of arrangement | - |
| Mar 27, 2000 | Interim Dividend | - |
| Jan 28, 2000 | Quarterly Results | - |
| Oct 28, 1999 | Quarterly Results | - |
| Jul 28, 1999 | Quarterly Results | - |
| May 26, 1999 | Accounts | - |
| Jan 29, 1999 | Quarterly Results | - |
| Oct 28, 1998 | Quarterly Results | - |
| Nov 28, 1997 | Half Yearly Results | - |
| Oct 29, 1997 | Accounts & Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
06 Jul 2024
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Filing of Intimation received from RTA regarding the loss of certificate by the shareholder.
05 Jul 2024
NOVARTIS INDIA LTD. - 500672 - Communication To Members Of The Company- Intimation On Tax Deduction On Dividend For The Financial Year 2023-24, If Declared, At The Ensuing Annual General Meeting To Be Held On July 31, 2024.
Communication to Members of the Company - Intimation on tax deduction on dividend for the financial year 2023-24 if declared at the ensuing Annual General Meeting to be held on July 31, 2024.
05 Jul 2024
NOVARTIS INDIA LTD. - 500672 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Reporting for the Financial year ended March 31, 2024 of Novartis India Limited
05 Jul 2024
NOVARTIS INDIA LTD. - 500672 - Reg. 34 (1) Annual Report.
Filing of Annual Report of Novartis India Limited
05 Jul 2024
NOVARTIS INDIA LTD. - 500672 - Notice Convening The 76Th Annual General Meeting Of Novartis India Limited To Be Held On July 31, 2024.
Notice convening the 76th Annual General Meeting of Novartis India Limited to be held on July 31, 2024
04 Jul 2024
NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation regarding pre-issue of Notice of AGM in Newspaper
04 Jul 2024
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under regulation 39(3) of SEBI (LODR), 2015 for loss of share certificates.
29 Jun 2024
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Filing of intimation regarding the loss of certificate by the shareholder as received from RTA dated June 29 2024 under the SEBI LODR.
28 Jun 2024
NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Change in Management
Announcement under regulation 30 of SEBI LODR for the appointment of Additional Director (designated as Whole Time Director) subject to the approval of members. The Board of Directors approved the said appointment at the Board meeting held on June 28, 2024.
28 Jun 2024
NOVARTIS INDIA LTD. - 500672 - Board Meeting Outcome for Board Meeting Outcome For Meeting Of Board Of Directors Of Novartis India Limited Held On June 28, 2024 For Appointment Of Additional Director (Designated As Whole Time Director)
Board Meeting outcome for meeting of Board of Directors of Novartis India Limited held on June 28, 2024 for appointment of additional Director (designated as Whole Time Director)
